A fluorescent “glue” of water triggered by hydrogen-bonding cross-linking

2016 ◽  
Vol 4 (47) ◽  
pp. 11050-11054 ◽  
Author(s):  
Dejia Wang ◽  
Hongwei Zhao ◽  
Hongjuan Li ◽  
Shiguo Sun ◽  
Yongqian Xu

As a “glue” of water, a small organic molecule with the novel hydrogen-bonding cross-linked aggregation-induced emission (AIE) property was designed to detect trace water, displaying a wide linear range (0–40%, v/v) in most of the organic solvents.

2017 ◽  
Vol 9 (18) ◽  
pp. 15744-15757 ◽  
Author(s):  
Ani Wang ◽  
Ruiqing Fan ◽  
Yuwei Dong ◽  
Yang Song ◽  
Yuze Zhou ◽  
...  

2021 ◽  
Vol 5 (1) ◽  
pp. 406-417
Author(s):  
Mengqian Yang ◽  
Jingran Deng ◽  
Huifang Su ◽  
Shuangxi Gu ◽  
Jie Zhang ◽  
...  

An organic small molecule T-BDP with D–A–D structure was designed and synthesized and could self-assemble into nanoparticles with significant AIE performance. Under 635 nm laser irradiation, T-BDP NPs ablate cancer cells through photodynamic/photothermal synergistic effects.


The Analyst ◽  
2018 ◽  
Vol 143 (13) ◽  
pp. 3068-3074 ◽  
Author(s):  
Shanliang Song ◽  
Yuping Zhang ◽  
Yizhou Yang ◽  
Chuanxi Wang ◽  
Ying Zhou ◽  
...  

A novel dual-emission fluorescent nanocomposite material, CDs/Cu NCs, was fabricated for detecting trace water in organic solvents (DMSO, DMF, THF, and ACN).


RSC Advances ◽  
2016 ◽  
Vol 6 (109) ◽  
pp. 107851-107858 ◽  
Author(s):  
Cui'e Zou ◽  
Duan Bin ◽  
Beibei Yang ◽  
Ke Zhang ◽  
Yukou Du

The novel Au–Ag nanorings/NG modified electrode was found to have a wide linear range from 0.05 μM to 241.2 μM (S/N = 3) with a low detection limit of 0.01 μM when it was employed for rutin detection.


2021 ◽  
Vol 10 (6) ◽  
pp. 1324
Author(s):  
Cosimo Mazzotta ◽  
Marco Ferrise ◽  
Guido Gabriele ◽  
Paolo Gennaro ◽  
Alessandro Meduri

The purpose of this study was to evaluate the effectiveness and safety of a novel buffered riboflavin solution approved for corneal cross-linking (CXL) in progressive keratoconus and secondary corneal ectasia. Following the in vivo preclinical study performed on New Zealand rabbits comparing the novel 0.25% riboflavin solution (Safecross®) containing 1% hydroxypropyl methylcellulose (HPMC) with a 0.25% riboflavin solution containing 0.10% EDTA, accelerated epithelium-off CXL was performed on 10 patients (10 eyes treated, with the contralateral eye used as control) through UV-A at a power setting of 9 mW/cm2 with a total dose of 5.4 J/cm2. Re-epithelialization was evaluated in the postoperative 7 days by fluorescein dye test at biomicroscopy; endothelial cell count and morphology (ECD) were analyzed by specular microscopy at the 1st and 6th month of follow-up and demarcation line depth (DLD) measured by anterior segment optical coherence tomography (AS-OCT) one month after the treatment. We observed complete re-epithelization in all eyes between 72 and 96 h after surgery (88 h on average). ECD and morphology remained unchanged in all eyes. DLD was detected at a mean depth of 362 ± 50 µm, 20% over solutions with equivalent dosage. SafeCross® riboflavin solution chemically-boosted corneal cross-linking seems to optimize CXL oxidative reaction by higher superoxide anion release, improving DLD by a factor of 20%, without adverse events for corneal endothelium.


Sign in / Sign up

Export Citation Format

Share Document